Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -100.51% is in line with its 5-year average of -104.67%, around the middle of its 5-year range (-229.84%–-38.14%).
As of the fiscal period ended Tuesday, June 30, 2026. 39.10% below its 12-month average of -72.25%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -100.51%.
RETURN ON INVESTED CAPITAL (ROIC)
-100.51%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-72.25%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-119.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-104.67%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-111.11%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-113.42%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-39.10%
CURRENT VS 3Y AVG
+15.62%
CURRENT VS 5Y AVG
+3.97%
CURRENT VS 10Y AVG
+9.54%
CURRENT VS 15Y AVG
+11.39%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-181.97%
vs the sector median at left
Phio Pharmaceuticals Corp.
Market Cap
$11.53M
Return on Invested Capital (ROIC)
-100.51%
TTM Avg
-72.25%
3Y Avg
-119.12%
5Y Avg
-104.67%
Market Cap
$11.59M
Return on Invested Capital (ROIC)
-32.27%
TTM Avg
-112.80%
3Y Avg
-113.13%
5Y Avg
-94.20%
Market Cap
$11.31M
Return on Invested Capital (ROIC)
-275.74%
TTM Avg
-139.56%
3Y Avg
-165.90%
5Y Avg
-125.03%
Market Cap
$11.12M
Return on Invested Capital (ROIC)
-59.42%
TTM Avg
-18.05%
3Y Avg
-54.95%
5Y Avg
-57.91%
Market Cap
$11.27M
Return on Invested Capital (ROIC)
-240.64%
TTM Avg
-174.03%
3Y Avg
-198.05%
5Y Avg
-242.53%
Market Cap
$11.08M
Return on Invested Capital (ROIC)
-216.67%
TTM Avg
-46.84%
3Y Avg
-98.66%
5Y Avg
-549.86%
Market Cap
$11.05M
Return on Invested Capital (ROIC)
-479.39%
TTM Avg
-317.58%
3Y Avg
-249.47%
5Y Avg
-183.14%
Market Cap
$12.19M
Return on Invested Capital (ROIC)
-19.53%
TTM Avg
-16.13%
3Y Avg
-40.26%
5Y Avg
-33.39%
Market Cap
$10.82M
Return on Invested Capital (ROIC)
-465.34%
TTM Avg
-276.05%
3Y Avg
-276.05%
5Y Avg
-276.05%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | $11.53M | -100.51% | -72.25% | -119.12% | -104.67% |
| Biofrontera Inc. (BFRI)vs › | $11.59M | -32.27% | -112.80% | -113.13% | -94.20% |
| VistaGen Therapeutics, Inc. (VTGN)vs › | $11.31M | -275.74% | -139.56% | -165.90% | -125.03% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.12M | -59.42% | -18.05% | -54.95% | -57.91% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.27M | -240.64% | -174.03% | -198.05% | -242.53% |
| BioVie Inc. (BIVI)vs › | $11.08M | -216.67% | -46.84% | -98.66% | -549.86% |
| Cerenome, Inc. (CNSY)vs › | $11.05M | -479.39% | -317.58% | -249.47% | -183.14% |
| IRIDEX Corporation (IRIX)vs › | $12.19M | -19.53% | -16.13% | -40.26% | -33.39% |
| Caring Brands, Inc. (CABR)vs › | $10.82M | -465.34% | -276.05% | -276.05% | -276.05% |
| Pluri Inc. (PLUR)vs › | $10.59M | -127.37% | -96.60% | -79.17% | -74.39% |
ROIC
-100.5%
ROE
-102.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -100.51% |
| 2026-03-31 | -67.14% |
| 2025-12-31 | -43.80% |
| 2025-09-30 | -76.08% |
| 2025-06-30 | -73.75% |
| 2025-03-31 | -57.93% |
| 2024-12-31 | -156.40% |
| 2024-09-30 | -151.35% |
| 2024-06-30 | -229.84% |
| 2024-03-31 | -166.04% |
| 2023-12-31 | -138.40% |
| 2023-09-30 | -161.58% |
| 2023-06-30 | -125.71% |
| 2023-03-31 | -169.94% |
| 2022-12-31 | -105.40% |
| 2022-09-30 | -89.59% |
| 2022-06-30 | -72.19% |
| 2022-03-31 | -63.88% |
| 2021-12-31 | -61.13% |
| 2021-09-30 | -49.21% |
| 2021-06-30 | -38.14% |
| 2021-03-31 | -31.82% |
| 2020-12-31 | -64.93% |
| 2020-09-30 | -56.22% |
| 2020-06-30 | -48.08% |
| 2020-03-31 | -74.36% |
| 2019-12-31 | -145.92% |
| 2019-09-30 | -100.11% |
| 2019-06-30 | -73.05% |
| 2019-03-31 | -59.78% |
| 2018-12-31 | -54.23% |
| 2018-09-30 | -435.49% |
| 2018-06-30 | -262.99% |
| 2018-03-31 | -1626.10% |
| 2017-12-31 | -678.72% |
| 2017-09-30 | -372.86% |
| 2017-06-30 | -211.03% |
| 2017-03-31 | -148.30% |
| 2016-12-31 | -83.05% |
| 2016-09-30 | -306.26% |
| 2016-06-30 | -192.95% |
| 2016-03-31 | -137.15% |
| 2015-12-31 | -115.15% |
| 2015-09-30 | -89.93% |
| 2015-06-30 | -73.31% |
| 2015-03-31 | -168.93% |
| 2014-12-31 | -112.36% |
| 2014-09-30 | -92.74% |
| 2014-06-30 | -77.41% |
| 2014-03-31 | -79.90% |
| 2013-12-31 | -162.87% |
| 2013-09-30 | -135.46% |
| 2013-06-30 | -119.90% |
| 2013-03-31 | -141.36% |
| 2012-12-31 | -331.61% |
| 2012-09-30 | -259.46% |
| 2012-06-30 | -213.81% |
